What does this source bring?
Cochrane 2025 indicates that pharmacological and optical interventions may reduce progression, but the certainty of results and long-term data are mixed.
Last Query 19.02.2024 . Does not include all tests with 2025–2026 ; poorly connected networks do not justify simple product ranking.
CLAIM-COCHRANEScope of testing and verification
- The role of the record
- Source of the claim
- Population
- Children 4–18 years old; 104 RCT
- N
- 17509
- Geography
- Globally
- Observation (months)
- 48
- Comparator
- Not applicable / no common comparator
- Result
- Cochrane 2025 indicates that pharmacological and optical interventions may reduce progression, but the certainty of results and long-term data are mixed.
- Safety
- This record does not allow estimation of the frequency of rare adverse events.
- Device/structure
- Not applicable / not determined within the verified range
- Publisher of the publication
- Wiley
- Financing
- National Eye Institute/NIH, grant UG1EY020522 (declaration in abstract).
- Conflicts of interest
- Not determined within the proven range. The absence of confirmation does not mean the absence of conflict.
- DOI
- 10.1002/14651858 .cd014758.pub3
- PMID
- 39945354
- What was checked
- Bibliographic metadata and abstract in Europe PMC / PubMed
- Date of verification
- 2026-09-09
This is the editorial card of the publication. The description does not replace the full text, supplementary data or instructions for a specific device.